- Doctors & Departments
- Conditions & Advice
- Your Visit
- Research & Innovation
With the expertise to treat virtually any condition affecting newborns, we strive to continually elevate care for the smallest, most vulnerable patients. Our research has been crucial to the development of several therapies used in neonatal intensive care units throughout the country, such as the use of inhaled nitric oxide for pulmonary hypertension and brain cooling for hypoxic brain injury. We continue to innovate, regularly ushering in new discoveries, practices, and techniques from the lab to the bassinet.
Our research targets improving outcomes for a variety of neonatal conditions, from the common — such as prematurity or fetal growth restriction — to the rare. Better outcomes mean a better standard of living for our patients. A few of our efforts include:
Our Level IV NICU — the highest designation awarded by the American Academy of Pediatrics — is among the first in the nation to be named a Center of Excellence for Neonatal Services by United Resource Networks. Because we see more than 300 infants annually who require surgery while in our NICU, our providers have diverse experience caring for a nearly unlimited array of rare and complex conditions.
Learn more about our Neonatology Program.
Until Noah Lindsay, pulmonary AVMs had never been documented in a living CDH patient. Until our unprecedented CDH treatment, they thought he couldn't be saved.